Beam Therapeutics shares owned by Farallon Capital Management
Quarter-by-quarter ownership of Beam Therapeutics (BEAM) shares owned by Farallon Capital Management
from 13F filings
Historical chart of Farallon Capital Management investment in Beam Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Beam Therapeutics held by Farallon Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Beam Therapeutics by Farallon Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $108M | 4.5M | 24.05 |
| 2023-06-30 | $110M | 3.4M | 31.93 |
| 2023-03-31 | $105M | 3.4M | 30.62 |
| 2022-12-31 | $133M | 3.4M | 39.11 |
| 2022-09-30 | $173M | 3.6M | 47.64 |
| 2022-06-30 | $134M | 3.5M | 38.71 |
| 2022-03-31 | $149M | 2.6M | 57.30 |
| 2021-12-31 | $181M | 2.3M | 79.69 |
| 2021-09-30 | $149M | 1.7M | 87.01 |
| 2021-06-30 | $193M | 1.5M | 128.71 |
| 2021-03-31 | $47M | 593k | 80.04 |
| 2020-03-31 | $3.1M | 170k | 18.00 |
More positions owned by Farallon Capital Management
View all positions for Farallon Capital Management